GW25-e0809 Intracoronary mesenchymal stem cells infusion after acute myocardial infarction: a meta-analysis on clinical trials  by Jie, Qin et al.
GW25-e1539
Effects of acute exercise on plasma FGF-21 level and glucose lipid metabolism
in male obese youth
Li Juan1, Chen Wei2
1PE college of Yan Shan University, 2Hebei Normal University of Science and
Technology
Objectives: Obesity is a serious health problem in worldwide, which is think the result
of genetic and environmental factors, especially an inappropriate lifestyle, character-
ized by high fat diet and physical inactivity. Obesity, insulin resistance and dyslipi-
demia often occur in concert, which in partly contribute to cardiovascular disease.
Physical exercise strongly encouraged for obese people due to physical inactivity is an
important contributor to the development of cardiovascular disease. Fibroblast growth
factor -21 (FGF-21) is a cytokine closely related to the glucose and lipid metabolism,
which is an important member of the ﬁbroblast growth factor family was found in
recent years, it mainly secreted by the liver and adipose tissue. it was recently shown
that FGF-21 levels were positively associated with physical activity levels in healthy
non obese people. Regular exercise also plays an important role in improving the level
of FGF-21. Recent research has also found that acute exercise can increase the level of
plasma FGF-21 and promote fat decomposition, improve insulin sensitivity in healthy
subjects. In the light of the improved insulin sensitivity by exercise depends in a large
extent on acute effects of exercise, acute exercise has been reported to play an
important role in improved glucose and lipid metabolism. However, whether acute
exercise inﬂuence FGF-21 level in obesity, and FGF-21 involved in the metabolism of
glucose and lipid process were unclear. To study the changes of plasma FGF-21,
blood glucose, serum insulin, free fatty acids after acute exercise in male obese youth,
in order to investigate acute effect of exercise on obese plasma FGF-21 and mecha-
nism regulated lipid.
Methods: Simple obesity male students (OG, n¼10) and healthy non obese male
students (CG, n¼10) take 2 different intensity exercise test (VO2max 50% vs VO2max
75%) respectively, the venous blood was collected in a quiet state, immediately after
exercise, 30min, 60min and120min. the plasma FGF-21, blood glucose, blood insulin
and free fatty acid levels were detected.
Results: The AUC of FGF-21 were negatively correlated with AUC of insulin after
two acute exercise in CG (r¼-0.613, P¼0.004), and positively correlated with AUC of
FFA (r¼0.536, P¼0.015) after two acute exercise, in addition, the AUC of FGF-21
were positively correlated with AUC of FFA (r¼0.568, P¼0.009) after two acute
exercise in OG.
Conclusions: There is a certain degree of FGF-21 resistance in obese young men. And
the response of FGF-21 to acute exercise is reduced in male obese youth compare with
healthy subjects; the increased level of FGF-21 may mediate glucose and lipid
metabolism regulated by acute exercise in healthy subjects, although the glyco-
metabolism was not inﬂuenced by increased FGF-21 induced by acute exercise, but
may contribute to their fat decomposition in male obese youth.Cardiovascular Disease Clinical Research
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Objectives: To perform a double-blinded, randomized, placebo-controlled trial to
determine the impact of CD133+ bone marrow cells (BMC) on left ventricular (LV)
function and clinical symptoms.
Methods: 70 patients with chronic ischaemic heart disease and impaired LV function
(left ventricular ejection fraction, LVEF <35%) were randomized (1:1) to inject
autologous CD133+ BMC and placebo in the non-transmural, hypokinetic infarct
border zone. Pre-operative LVEF was 297% in CD133+ patients and 286% in
placebo patients. Outcome was assessed after 6 months, and the primary endpoint was
LVEF measured by cardiac magnetic resonance imaging (MRI) at rest.
Results: There was no difference in 5-min walking distance between groups at follow-
up, and New York Heart Association class improved more in the placebo group (P ¼
0.004). CD133+ BMC treated patients showed a better recovery of regional wall
motion when the target area was posterior by echocardiography. By cardiac MRI,
LVEF at 6 months was 358% in the placebo group and 337% in BMC group (P ¼
0.42), with an average inter-group difference of -2.4% (95% CI -6.2-2.6). Systolic or
diastolic LV volume at 6 months was not different. In the CD133+ group, myocardialC116 JACC Vol 64/16/Suppl C j October 16–1perfusion at rest recovered better in LV segments than in the placebo group (10 vs.
3%, P<0.001). Scar mass decreased by 2.56 g in CD133+ patients (P ¼ 0.05), but
was unchanged in the placebo group (0.46 g, P ¼ 0.6; inter-group difference in
change ¼ 2.5 g (95% CI -1.5-4.8)).
Conclusions: Although there may be some improvements in scar size and regional
perfusion, intra-myocardial injection of CD133+ BMC has no effect on global LVEF
and clinical symptoms.
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Objectives: To evaluate the effectiveness and safety of CSWT for treatment of CAD
patients without coronary artery revascularization.
Methods: A total of 87 CAD patients without coronary artery revascularization
were enrolled in this study, 68 male and 19 female, aged from 43 to 80 years
(66.808.41 years). The patients were divided into three group by using randomised
single-blind method, Group A enrolled 32 cases (received 9 spots treatment of each
ischemia target region), Group B enrolled 30 cases (received 25 spots treatment of
each ischemia target region). In the course of 3 months, nine CSWT procedures were
performed in all of the patients. And 25 patients were in Group C (treated with the
same procedures but without the shock wave energy). Before the CSWT (0 month)
and the follow-up of 3 months, 6 months, 12 months, Patients of three groups were
received the examinations include the 99mTc-MIBI myocardial perfusion and 18F-
FDG myocardial metabolism SPECT to identify the myocardial ischemia and viability
segments. Canadian Cardiovascular Society (CCS) angina scale, New York Heart
Association (NYHA) class, Seattle Angina Questionnaire (SAQ) scale, nitroglycerin
used dosage, 6-min walk test (6MWT), Left ventricular ejection fraction (LVEF), left
ventricular end diastolic dimension (LVEDD) and so on to evaluate the effect of
CSWT.
Results: During the CSWT, the angina of the patients was not to be worse and no
heart failure, no hemorrhage, no embolism, no malignant arrhythmia (ventricular
tachycardia/ﬁbrillation), no myocardial necrosis as well as no any obvious changes on
blood pressure, heart rate and blood oxygen saturation. In follow-up from 3 months to
12 months, the NYHA class, CCS angina scale, SAQ scale, 6MWT and nitroglycerin
used dosage in group A and group B improved signiﬁcantly compared with group C
(P<0.05). Follow-up to 6 months, the above mentioned parameters of group B
improved signiﬁcantly than group A (P<0.05). LVEF of the group B at 12 months
follow-up improved signiﬁcantly compared with group A (P<0.05). The differences
of LVEF in group C have no statistical signiﬁcance (P>0.05). However, follow-up to
12 months LVEDD in group C signiﬁcant enlarged than 0 month (P<0.05). During
follow-up, the myocardial ischemic segments, dysbolism segments, total radioactive
score of perfusion imaging, total radioactive score of metabolism imaging of group A
and group B improved signiﬁcantly compared with group C (P<0.05), and the above
mentioned parameters of group B improved signiﬁcantly than group A (P<0.05).
Follow-up to 12 months the above mentioned parameters of group C signiﬁcant worse
than the baseline value (P<0.05).
Conclusions: (1) CSWT is a non-invasive, safe, effective, easy to duplicate, new
method to promote myocardial angiogenesis. (2) CSWT could relieve myocardial
ischemia related symptoms in the early stage, improved myocardial perfusion and
metabolism, increased the coronary artery reserve, life quality and exercise tolerance
increased too, it can restrain cardiac remodeling and improved the heart function. (3)
CSWT could use for the end-stage or non-end-stage CAD patients who have not
received revascularization treatment. (4) It seems that expanding the range of treat-
ment could obvious improve myocardial perfusion, myocardial metabolism and heart
function than the conventional treatment protocols.
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Objectives: This meta-analysis aims to evaluate the efﬁcacy of mesenchymal stem
cells (MSCs) therapy in patients with acute myocardial infarction.
Methods: A random-effects meta-analysis was performed on randomized controlled
trials (RCTs) investigating the effects of MSCs therapy in patients with acute
myocardial infarction that were published from January 2000 to January 2014. The
end points were left ventricular (LV) ejection fraction, LV end-systolic and end-dia-
stolic volumes, infarct size, and major adverse cardiac and cerebrovascular event rates.
Results: Combining the results of 28 RCTs, LV ejection fraction increased by +2.25%
(95% conﬁdence interval [CI], 0.68-3.52; P<0.01) in the MSCs group as compared
with controls, evoked by a preservation of LV end-systolic volume (-4.05 mL; 95% CI
-6.91- -1.18; P<0.01) and a reduction in infarct size (-2.69%; 95% CI -4.83- -0.56;
P<0.01). There is no effect on cardiac function, volumes, or infarct size in RCTs
(n¼11) that used magnetic resonance imaging (MRI) -derived end points. No9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
beneﬁcial effect could be detected on major adverse cardiac and cerebrovascular event
rates after MSCs infusion 6 months later.
Conclusions: Intracoronary infusion of MSCs does not improve clinical outcome and
cardiac function on MRI-derived parameters.
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Objectives: To investigate correlation between P2Y12 gene polymorphisms
(rs2046934, rs6787801, rs6798347 and rs6787801) and coronary heart disease.
Methods: 455 patients with coronary artery disease who were diagnosed by coronary
angiography or coronary artery CT angiography and 90 health control individuals
were enrolled in this study. The single nucleotide polymorphisms rs2046934,
rs6787801, rs6798347 and rs6787801 of P2Y12 gene were detected by MassARRAY
Time of Flight Mass Spectrometry. The genotypes and allele frequencies in the two
groups were compared.
Results: Genotypes and frequencies of P2Y12 gene polymorphisms rs2046934 in
coronary heart disease group and control group were as below: CC genotype 2.4%
vs. 4.4%, TT genotype 71.0% vs. 74.4%, CT genotype 26.6% vs. 21.2%; and C allele
frequencies were 2.4% vs. 4.4%, T allele frequencies were 84.3% vs. 85.0%. There
was no signiﬁcant difference between the two groups (P>0.05). Genotypes and
frequencies of P2Y12 gene polymorphisms rs6787801 in coronary heart disease
group and control group were: GG genotype 17.4% vs. 17.8%, AA genotype 36.9%
vs. 31.3%, GA genotype 45.7% vs. 51.1%; and G allele frequencies 40.2% vs.
43.3%; A allele frequencies 59.8% vs. 56.7%. There was no signiﬁcant difference
between these two groups (P>0.05). Genotypes and frequencies of P2Y12 gene
polymorphisms rs6798347 in coronary heart disease group and control group were as
below: AA genotype 9.1% vs. 6.7%, GG genotype 41.6% vs. 52.2%, AG genotype
49.3% vs. 41.1%; and A allele frequencies 29.9% vs. 27.2%, G allele frequencies
70.1% vs. 72.8%. There was no signiﬁcant difference between control group and
coronary heart disease group (P>0.05). Genotypes and frequencies of P2Y12 gene
polymorphisms rs6801273 in coronary heart disease group and control group were as
below: CC genotype 13.4% vs. 10.0%, TT genotype 42.6% vs. 50.0%, CT genotype
44.0% vs. 40.0%; and C allele frequencies 35.4% vs. 30.0%, T allele frequencies
64.6% vs. 70.0%. There was no signiﬁcant difference between the compared groups
(P>0.05).
Conclusions: Single Nucleotide Polymorphisms of P2Y12 gene polymorphisms in
rs2046934, rs6787801, rs6798347 and rs6798347 are not associated with coronary
heart disease.
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Objectives: Vascular endothelial injury caused by hypertension, hyperlipidemia,
hyperglycemia, and other risk factors often lead to vascular endothelial dysfunction,
intimal hyperplasia, chemotaxis of inﬂammatory cytokine secreting cells, and
accumulation of lipid deposits. As a result, coronary atheroscleroticplaque may
occur. Recent studies have suggested that similar to the myocardium and coronary
artery, epicardial adipose tissue (EAT), which is composed of adipocytes, macro-
phages, and monocytes, may produce numerous inﬂammatory cytokines. More
speciﬁcally, inﬂammatory cytokines secreted by EAT contribute to plaque insta-
bility. In this study we investigate how CHD and coronary atheroscleroticplaque
vulnerability are associated with epicardial adipose tissue volume (EATV) and the
inﬂammatory cytokines, matrix metalloproteinase-9 (MMP9) and leptin, derived
from EAT.
Methods: 260 patients were assessed for severity of coronary artery stenosis and
EATV by 64-slice dual-source cardiac computed tomography (CT) scans. These
patients were also screened to determine levels of adipokines in pericardial blood
and insulin resistance indices. Out of the 260 patients, 180 patients were conﬁrmed
to have CHD utilizing digital subtraction angiography (DSA), and the other 80
patients (40 of whom were assessed prior to valve replacement surgery) were
classiﬁed as non-CHD. The vascular remodeling indices and plaque vulnerability
parameters (lipid plaque volume, ﬁbrous plaque volume, and calciﬁed plaque vol-
ume) were measured in order to determine any signiﬁcant correlations with EATV.
Samples of EAT and thoracic adipose tissue (TAT) were collected during the cor-
onary artery bypass graft (CABG) surgery that 40 of the CHD patients received.
Samples were probed for mRNA level and protein level expression of leptin and
MMP9.
Results: (1) The EATVs were signiﬁcantly higher in the CHD group compared to
those of the NCHD group. (2) Subgroup analysis of the CHD patients demon-
strated that EATV in patients with positive remodeling was signiﬁcantly higher
(127.6342.00 cm3 vs. 95.4925.36 cm3) than that of the non-positiveJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cremodeling group. Lipid plaque volume was positively correlated with EATV (P
¼ 0.04, r¼ 0.07); however, ﬁber plaque volume was negatively correlated with
EATV (P ¼ 0.0077, r¼ -0.06). (3) Logistic regression analysis indicated that
EATV is an independent risk factor for positive vascular remodeling. (4)
Compared to 40 NCHD patients, the 40 CHD patients who received CABG sur-
gery, presented higher levels of mRNA and protein expression of leptin and
MMP9 in EAT (P<0.01). However, there was no signiﬁcant difference (P> 0.05)
in mRNA and protein expression of leptin and MMP9 within the TAT of CHD and
NCHD patients. (5) In the CHD group, leptin and MMP9 levels in EAT and EATV
were positively correlated with lipid plaque volume and ﬁbrous plaque volume
(P<0.05).
Conclusions: Epicardial adipose tissue volume (EATV) and EAT-derived inﬂam-
matory cytokines are signiﬁcantly correlated with plaque vulnerability in coronary
heart disease (CHD). It has been determined that EATV is an independent risk factor
for both CHD and plaque vulnerability. Levels of inﬂammatory cytokines secreted by
EAT and TAT of CHD patients were found to be signiﬁcantly greater than those of
NCHD patients. Levels of inﬂammatory cytokines produced by EAT correlate with
EATVs; therefore, controlling levels EATV and inﬂammation may reduce plaque
vulnerability and decrease the risk of coronary heart disease.
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Objectives: The dynamic variance of plasma superoxide dismutase (SOD) and
malondialdehyde (MDA) in acute myocardial infarction after ischemic post-
conditioning has not been reported. The present study was to explore the effect of
ischemic postconditioning on plasma superoxide dismutase (SOD) and malondialde-
hyde (MDA) in acute ST-segment elevated myocardial infarction and clinical
signiﬁcance.
Methods: One hundred twenty patients [aged (6016) years; 86% male] of acute
myocardial infarction treated with emergency percutaneous coronary intervention
(PCI) were randomly assigned to a postconditioning or standard protocol. The plasma
SOD and MDA concentrations at 4, 8, 12, 16, 20, 24, 36, and 48 hours after the PCI
were compared respectively, and left ventricular ejection fraction (LVEF), left ven-
tricular end-diastolic volume index (LVEDVI), left ventricular end-systolic volume
index (LVESVI), region wall movement index (RWMI) after the operation for 2
weeks, and occurrence rate of cardiac events after the operation for a year were
compared between two groups.
Results:With similar time-to reperfusion [(16866) minutes in the postconditionging
group vs. (15660) minutes in the standard group, P¼0.56], the plasma SOD values
in the postconditionging group were higher [(115.333.7) ng/ml vs. (90.434.6) ng/
ml, P¼0.011] at 4 h, [(127.3.738.5) ng/ml vs. (95.532.1) ng/ml, P¼0.023] at 8 h,
[(129.243.5) ng/ml vs. (98.634.8) ng/ml, P¼0.021] at 12 h, [(118.337.7) ng/ml
vs. (95.432.6) ng/ml, P¼0.020] at 16 h, [(109.737.5) ng/ml vs. (83.532.8) ng/ml,
P¼0.033] at 20 h, [(117.233.5) ng/ml vs. (89.633.8) ng/ml, P¼0.017] at 24 h,
[(110.334.7) ng/ml vs. (88.434.8) ng/ml, P¼0.031] at 36 h, [(107.3.730.5) ng/ml
vs. (85.530.1) ng/ml, P¼0.043] at 48 h respectively than those in the standard
group. The MDA concentrations in the postconditionging group were lower
[(1.140.44) mmol/l vs. (2.680.66) mmol/l, P¼0.021] at 4 h, [(1.560.47) mmol/l
vs. (3.141.11) mmol/l, P¼0.031]at 8 h, [(1.870.77) mmol/l vs. (4.241.99) mmol/
l, P¼0.021] at 12 h, [(1.770.76) mmol/l vs. (4.011.84) mmol/l, P¼0.018] at 16 h,
[(1.650.65) mmol/l vs. (3.841.76) mmol/l, P¼0.023] at 20 h, [(1.450.47) mmol/l
vs. (3.231.33) mmol/l, P¼0.031] at 24 h, [(1.080.39) mmol/l vs. (2.290.96)
mmol/l, P¼0.044] at 36 h, [(0.780.37) mmol/l vs. (1.740.56) mmol/l, P¼0.043] at
48 h respectively than those in the standard group. After the operation for 2 weeks,
LVEF increased [(50.64.2) % vs. (47.55.3) %, P¼0.011], LVESVI [(31.35.1)
ml/m2 vs. (35.77.2) ml/m2, P¼0.008] and LVEDVI [(57.55.3) ml/m2 vs.
(61.85.9) ml/m2, P¼0.009] and RWMI [(1.510.46) vs. (1.730.52), P¼0.034]
decreased in the postconditionging group compared with the standard group respec-
tively. After the operation for a year, the occurrence rate of cardiac events in the
postconditionging group was signiﬁcantly lower (3.3% vs. 10.3%, P¼0.030] than that
in the standard group.
Conclusions: Ischemic postconditioning can increase plasma SOD concentration and
decrease MDA value between 4 hours and 48 hours after the PCI, and improve cardiac
function, left ventricular remodeling and prognosis in acute ST-segment elevated
myocardial infarction.
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